Treatment of two cases of chronic kidney disease with dietotherapy (ilaj-bil-ghiza), regimenal therapy (bukhoor aam) and Unani drugs without dialysis

Shabnam Ansari; Mohammad Maaz; Shah Alam; Sazid Alam; Ijhar Ahmad

doi:10.5667/CellMed.2020.0017

Treatment of two cases of chronic kidney disease with dietotherapy (ilaj-bil-ghiza), regimenal therapy (bukhoor aam) and Unani drugs without dialysis

CELLMED
Abbr : CellMed
2020, 10(2), pp.17-17
DOI : 10.5667/CellMed.2020.0017
Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
Research Area : Medicine and Pharmacy > General Medicine
Received : November 1, 2019
Accepted : February 17, 2020
Published : May 29, 2020

Shabnam Ansari ¹, Mohammad Maaz ², Shah Alam ³, Sazid Alam ⁴, Ijhar Ahmad ⁵

¹Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia
²Department of Moalajat, School of Unani medical education and research, Jamia Hamdard
³Central council for research in Unani medicine
⁴Department of Moalajat (Medicine), Sufia Unani medical college hospital and research center
⁵Jamia Hamdard

Candidate

ABSTRACT

Background: Chronic kidney disease (CKD) is affective a large portion of the world population prompting the need for extensive healthcare resources such as lifelong dialysis or kidney transplantation. The beneficial effect of conventional therapy in controlling the CKD progression remains a challenge due to their relative efficacy, safety, and accessibility. On the other hand, Unani medicine provides a therapeutic regimen that consists of a combination of treatment from rehabilitation to herbal pharmacotherapy. Methods: Two cases of chronic kidney disease were treated with dietotherapy, regimenal therapy (‘bukhoor aam’) and oral herbal drugs for 2-3 weeks. Endpoints of evaluation were symptoms and signs of the CKD, kidney function test, urine albumin, urine RBC, hemoglobin and liver function test. Result: Notable improvement was observed in the endpoints. Conclusion: Unani treatment was observed preliminarily beneficial in the treatment of chronic kidney disease. Rigorous pharmacological and clinical studies should be performed to warrant their efficacy and safety in CKD individuals.

KEYWORDS

Chronic kidney disease, Unani medicine, nephropathy, ilaj bil tadbeer, bukhoor, dietotherapy, ilaj bil ghiza, dialysis, regimenal therapy

Citation status

* References for papers published after 2023 are currently being built.

[journal] Afzal M / 2003 / Diuretic and nephroprotective effect of Jawarish Zarooni sada–a poly herbal Unani formulation / Journal of Ethnopharamacology 91 : 219~223

[journal] Alam A / 2016 / nephroprotective effect and unani medicine : a review / J Nephrol Ther 6 : 236~

[report] Amin KMY / 1994 / Anti-nephritic Syndrome ethnic drug Bisehri booti (A. Lanata)–An experimental study of relevant pharmacological actions / Abstract book IV of International congress of Ethno biology) : 99~

[web] Anonymous / About chronic kidney disease / https://www.kidney.org/atoz/content/about-chronic-kidney-disease

[journal] Bozorgi M. / 2017 / Antioxidant property of majoon-e-dabeed-ul-ward: a traditional herbal formulation in persian medicine / Tradit. Integr. Med 2 : 172~176

[journal] Cremer L / 1998 / A purified green barley extract with modulatory properties upon TNF alpha and ROS released by human specialized cells isolated from RA patients / Roumian Archives of Microbiology and Immunology 57(3-4) : 231~242

[journal] Gosmanov AR / 2014 / Diagnosis and treatment of diabetic kidney disease / Am. J. Med. Sci 347 : 406~413

[book] Hamdani KH / 2011 / Usoole tibb / National council for promotion of Urdu language : 483~

[journal] Hokazono H / 2010 / Anti-hyperuricemic effect of fermented barley extract is associated with increased urinary uric acid excretion / Food Science and Technology Research 16(4) : 295~304

[journal] Jainu M / 2004 / Antioxidant effect of methanolic extract of solanum nigrum berrieson aspirin induced gastric mucosal injury / Indian Journal of Clinical Biochemistry 19(1) : 57~61

[journal] Khaliq T / 2013 / Nephroprotective Potential of Rosa damascena Mill Flowers, Cichoriumintybus LinnRoots and Their Mixtures on Gentamicin-Induced Toxicity in Albino Rabbits / Pak Vet J 35 : 43~47

[journal] Luyckx VA / 2018 / The global burden of kidney disease and the sustainable development goals / Bulletin of the World Health Organization 96 : 414~422

[journal] Patil PS / 2015 / In vitro antioxidant and free radical scavenging activity of extracts of rosa damascenaflower petals / American Journal of Phytomedicine and Clinical Therapeutics 3(09) : 589~601

[journal] Rasane P / 2015 / Nutritional advantages of oats and opportunities for its processing as value added foods-a review / J Food Sci Technol 52(2) : 662~675

[journal] Salama AM / 2016 / Protective effect of solanum nigrumon nephrotoxicity in animals treated with antitumor drug(cisplatin) / International Journal of Advanced Research 4(2) : 1013~1019

[book] Sina I. / 2010 / Alqanoon Fit-tibb / Aijaz publishing house

[journal] Thomas R / 2008 / Chronic kidney disease and its complications / Prim Care 35(2) : 329~

[journal] Wang Y / 2019 / Chicory (Cichorium intybus L.) inhibits renal reabsorption by regulating expression of urate transporters in fructose-induced hyperuricemia / Journal of Traditional Chinese Medical Sciences 6(1) : 84~94

[journal] Wojcikowski K / 2006 / Herbs or natural substances as complementary therapies for chronic kidney disease : ideas for future studies / J Lab Clin Med 147 : 160~166

[journal] Zaman R / 2017 / Nephroprotective effect of Beekh Kasni(Roots of Cichorium intybus)in the form of methanolic and aqueous extract in Gentamycin induced rat models / Journal of Pharmacognosy and Phytochemistry 6(3) : 337~341

[journal] ZhongY / 2013 / Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases / Kidney Int 84(6) : 1108~1118

KJCKorea
Journal Central

CELLMED 2023 KCI Impact Factor : 0.03

Treatment of two cases of chronic kidney disease with dietotherapy (ilaj-bil-ghiza), regimenal therapy (bukhoor aam) and Unani drugs without dialysis

ABSTRACT

KEYWORDS

Citation status

* References for papers published after 2023 are currently being built.

CELLMED 2023 KCI Impact Factor : 0.03

Treatment of two cases of chronic kidney disease with dietotherapy (ilaj-bil-ghiza), regimenal therapy (bukhoor aam) and Unani drugs without dialysis

ABSTRACT

KEYWORDS

Statistics

Tools

Issue List

Citation status

KCI Citation Counts (0)

REFERENCES (21) * References for papers published after 2023 are currently being built.

Search PDF

Citation

* References for papers published after 2023 are currently being built.